Immix Biopharma (IMMX) Other Non-Current Assets (2022 - 2026)
Immix Biopharma (IMMX) reported Other Non-Current Assets of $20,418 for Q2 2026, down 81.5% from $110,606 a year earlier and down 87.6% from the prior quarter.
Powered by 
Analysis
Immix Biopharma (IMMX) Other Non-Current Assets (2022 - 2026) Analysis & Trends
At the end of FY2025, Immix Biopharma posted Other Non-Current Assets of $93,630, up 358.6% from FY2024.
- Other Non-Current Assets has a three-year compound annual growth rate of 140.6% (FY2022 to FY2025).
- By year, Other Non-Current Assets came in at $20,418 in FY2024 (-76.6%), $87,229 in FY2023 and $6,724 in FY2022.
- Five-year quarterly Other Non-Current Assets spans a low of $6,724 in Q4 2022 and a high of $175,131 in Q1 2023.
- Year over year, Other Non-Current Assets gained in four of the last eight quarters, with growth averaging 214.5%.
- The high point for year-over-year Other Non-Current Assets in five years was Q1 2026 (growth of 706.8%); the low point was Q1 2024 (a decline of 88.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $164,723 (Q1 2026), $93,630 (Q4 2025) and $111,689 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 7.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 14.27 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 10.73 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 19.60 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 12.98 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 4.75 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 9.94 Bn |
| 10 | Immix Biopharma | 541.74 Mn | 309.64 Mn | - | 20,418.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20,418.00 |
| Mar 31, 2026 | 185,141.00 |
| Dec 31, 2025 | 114,048.00 |
| Sep 30, 2025 | 132,107.00 |
| Jun 30, 2025 | 131,024.00 |
| Mar 31, 2025 | 20,418.00 |
| Dec 31, 2024 | 20,418.00 |
| Sep 30, 2024 | 20,418.00 |
| Jun 30, 2024 | 20,418.00 |
| Mar 31, 2024 | 20,418.00 |
| Dec 31, 2023 | 87,229.00 |
| Sep 30, 2023 | 103,191.00 |
| Jun 30, 2023 | 56,724.00 |
| Mar 31, 2023 | 175,131.00 |
| Dec 31, 2022 | 6,724.00 |
API Access
Immix Biopharma Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=IMMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "IMMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=IMMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();